[Effect of atorvastatin therapy on the level of secretory phospholipase A2 group IIA and on the modification of low density lipoproteins in patients with ischemic heart disease].
Pirkova, A A
[Effect of atorvastatin therapy on the level of secretory phospholipase A2 group IIA and on the modification of low density lipoproteins in patients with ischemic heart disease]. [electronic resource] - Kardiologiia 2007 - 37-40 p. digital
Publication Type: Clinical Trial; Journal Article
0022-9040
Aged
Anticholesteremic Agents--therapeutic use
Atorvastatin
Cholesterol--blood
Group II Phospholipases A2--blood
Heptanoic Acids--therapeutic use
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Lecithins--blood
Lipoproteins, LDL--blood
Lysophosphatidylcholines--blood
Male
Middle Aged
Myocardial Ischemia--blood
Pyrroles--therapeutic use
Treatment Outcome
Triglycerides--blood
[Effect of atorvastatin therapy on the level of secretory phospholipase A2 group IIA and on the modification of low density lipoproteins in patients with ischemic heart disease]. [electronic resource] - Kardiologiia 2007 - 37-40 p. digital
Publication Type: Clinical Trial; Journal Article
0022-9040
Aged
Anticholesteremic Agents--therapeutic use
Atorvastatin
Cholesterol--blood
Group II Phospholipases A2--blood
Heptanoic Acids--therapeutic use
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Lecithins--blood
Lipoproteins, LDL--blood
Lysophosphatidylcholines--blood
Male
Middle Aged
Myocardial Ischemia--blood
Pyrroles--therapeutic use
Treatment Outcome
Triglycerides--blood